- Early 1990s: The Tactile Communication and Neurorehabilitation Laboratory (TCNL) was founded at the University of Wisconsin-Madison.
- Late 2000s: TCNL developed and built the Portable Neuromodulation Stimulator (PoNS™) device and principals formed Advanced NeuroRehabilitation, LLC (ANR).
- 2013: ANR and MPJ Healthcare formed NeuroHabilitation Corporation, which signed a Collaborative Research and Development Agreement (CRADA) with the US Department of Defense.
- 2014: Helius Medical Technologies acquired NeuroHabilitation in a reverse merger and became a publicly traded company on the Canadian Securities Exchange.
- 2016: Helius Medical Technologies was listed on the Toronto Stock Exchange (TSX).
- 2017: Helius completed a multi-site, double-blind, randomized, sham-controlled registrational clinical trial investigating the safety and effectiveness of the Portable Neuromodulation Stimulator (PoNS™) in subjects with a chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI)
- 2018: Helius Medical Technologies was listed on NASDAQ
- 2018: NeuroHabilitation Corporation was renamed Helius Medical, Inc, (“Helius Medical”)
Stock Quote - HSDT
*Delayed quote courtesy of Google.